| 缩写名/全名 |
BLOOD REV
BLOOD REVIEWS |
||||||||||||||||||||
| ISSN号 | 0268-960X | ||||||||||||||||||||
| 研究方向 | 医学-血液学 | ||||||||||||||||||||
| 影响因子 | 2015:6.627, 2016:6.342, 2017:6.6, 2018:6.125, 2019:5.823, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 48 | ||||||||||||||||||||
| 出版年份 | 1987 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 约稿?周期不定 |
||||||||||||||||||||
| 录用比例 | 较难 | ||||||||||||||||||||
| 投稿链接 | http://ees.elsevier.com/bloodreviews/default.asp?pg=login.asp | ||||||||||||||||||||
| 投稿官网 | http://www.bloodreviews.com/ | ||||||||||||||||||||
| h-index | 85 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0268-960X%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications. Author: Hu Y, Cui Q, Luo C, Luo Y, Shi J, Huang H. Journal: Blood Rev. 2016 May;30(3):179-88. doi: 10.1016/j.blre.2015.11.002. Epub 2015 Nov 25. Review. PubMed |
| 2. | Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia. Author: Torka P, Al Ustwani O, Wetzler M, Wang ES, Griffiths EA. Journal: Blood Rev. 2016 May;30(3):201-11. doi: 10.1016/j.blre.2015.11.004. Epub 2015 Dec 3. Review. PubMed |
| 3. | Autophagy as a target for hematological malignancy therapy. Author: Dong Z, Liang S, Hu J, Jin W, Zhan Q, Zhao K. Journal: Blood Rev. 2016 Apr 16. pii: S0268-960X(16)30013-3. doi: 10.1016/j.blre.2016.04.005. [Epub ahead of print] Review. PubMed |
| 4. | Autophagy as a target for hematological malignancy therapy Author: Kewen Zhao Journal: Blood Reviews, 2016. |
| 5. | Autophagy as a target for hematological malignancy therapy Author: Zhiwu Dong Journal: Blood Reviews, 2016. |
| 6. | Autophagy as a target for hematological malignancy therapy Author: Zhiwu Dong, Shuang Liang, Jun Hu, Weiyun Jin, Qilin Zhan, Kewen Zhao Journal: BLOOD REVIEWS, 2016, Vol.30, 369-380, DOI:10.1016/j.blre.2016.04.005 DOI |
| 7. | A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications Author: Yongxian Hu, Qu Cui, Chao Luo, Yi Luo, Jimin Shi, He Huang Journal: BLOOD REVIEWS, 2016, Vol.30, 179-188, DOI:10.1016/j.blre.2015.11.002 DOI |
| 8. | The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology? Author: Shen-Miao Yang, Jian-Yong Li, Robert Peter Gale, Xiao-Jun Huang Journal: BLOOD REVIEWS, 2015, Vol.29, 205-213, DOI:10.1016/j.blre.2014.12.001 DOI |
| 9. | Drug resistance-related microRNAs in hematological malignancies: Translating basic evidence into therapeutic strategies Author: Lingling Xie, Rongrong Jing, Jing Qi, Zenghua Lin, Shaoqing Ju Journal: BLOOD REVIEWS, 2015, Vol.29, 33-44, DOI:10.1016/j.blre.2014.09.005 DOI |
|
|
